Daniel Alkon is the founder of Synaptogenix. Alkon is the President and Chief Science Officer (CSO) at Synaptogenix.
Daniel L. Alkon is the President and Chief Science Officer (CSO) at Synaptogenix, a clinical-stage biopharmaceutical company. He is responsible for leading the company's scientific strategy to develop restorative therapeutics for neurodegenerative diseases and developmental disorders.
Full founder directory · Investor directory · Company funding database · Fundraising library
The Startup Fundraising Platform
Raise funds for your startup
Find the right investors and get real replies — instantly, powered by AI.
Takes 30 seconds · No credit card · Cancel anytime
Slide-by-slide guide